[go: up one dir, main page]

ZA987660B - Novel tissue-specific calpains, their preparation and use. - Google Patents

Novel tissue-specific calpains, their preparation and use.

Info

Publication number
ZA987660B
ZA987660B ZA9807660A ZA987660A ZA987660B ZA 987660 B ZA987660 B ZA 987660B ZA 9807660 A ZA9807660 A ZA 9807660A ZA 987660 A ZA987660 A ZA 987660A ZA 987660 B ZA987660 B ZA 987660B
Authority
ZA
South Africa
Prior art keywords
preparation
novel tissue
calpains
specific
specific calpains
Prior art date
Application number
ZA9807660A
Inventor
Thomas Boehm
Neil T Dear
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA987660B publication Critical patent/ZA987660B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472Cysteine endopeptidases (3.4.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96466Cysteine endopeptidases (3.4.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
ZA9807660A 1997-08-26 1998-08-25 Novel tissue-specific calpains, their preparation and use. ZA987660B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737105A DE19737105A1 (en) 1997-08-26 1997-08-26 New tissue-specific calpains, their production and use

Publications (1)

Publication Number Publication Date
ZA987660B true ZA987660B (en) 2000-02-25

Family

ID=7840195

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9807660A ZA987660B (en) 1997-08-26 1998-08-25 Novel tissue-specific calpains, their preparation and use.

Country Status (13)

Country Link
EP (1) EP1009811A2 (en)
JP (1) JP2001513992A (en)
KR (1) KR20010023282A (en)
CN (1) CN1277634A (en)
AU (1) AU9263598A (en)
BR (1) BR9811365A (en)
CA (1) CA2301815A1 (en)
DE (1) DE19737105A1 (en)
HU (1) HUP0004027A2 (en)
IL (1) IL134361A0 (en)
NO (1) NO20000961L (en)
WO (1) WO1999010480A2 (en)
ZA (1) ZA987660B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928021A1 (en) * 1999-06-18 2000-12-21 Basf Ag New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders
AU7476900A (en) * 1999-09-09 2001-04-10 Millennium Pharmaceuticals, Inc. 26176, a novel calpain protease and uses thereof
AUPQ656500A0 (en) * 2000-03-28 2000-04-20 Autogen Pty Ltd A method of treatment and agents for same
WO2001073073A2 (en) * 2000-03-28 2001-10-04 Bayer Aktiengesellschaft Regulation of human neutral protease-related enzyme
CA2479780A1 (en) * 2001-04-04 2002-10-17 Universite De Montreal Antisense calpain nucleotides and uses thereof
JP4593404B2 (en) * 2005-08-29 2010-12-08 シスメックス株式会社 Liquid sample suction monitoring method and apparatus, and liquid sample analyzer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002634A1 (en) * 1994-07-15 1996-02-01 Cephalon, Inc. Active calpain expressed by baculovirus
EP0799892A3 (en) * 1996-04-05 1998-08-12 Takeda Chemical Industries, Ltd. Calpain, its production and use

Also Published As

Publication number Publication date
CA2301815A1 (en) 1999-03-04
WO1999010480A2 (en) 1999-03-04
IL134361A0 (en) 2001-04-30
BR9811365A (en) 2000-08-22
JP2001513992A (en) 2001-09-11
DE19737105A1 (en) 1999-03-04
WO1999010480A3 (en) 1999-05-27
KR20010023282A (en) 2001-03-26
AU9263598A (en) 1999-03-16
EP1009811A2 (en) 2000-06-21
NO20000961L (en) 2000-04-14
NO20000961D0 (en) 2000-02-25
CN1277634A (en) 2000-12-20
HUP0004027A2 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
ZA972727B (en) A novel composition, its preparation and use.
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
ZA975013B (en) Modified factor VII.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
SI1019358T2 (en) 3,3-diarylpropylamines , their use and preparation
HK1019774A1 (en) Etching composition and use thereof.
ZA983148B (en) Modified TNFÓ, DNA encoding such modified TNFÓ and vacines comprising said TNFÓ and DNA.
ZA964711B (en) Novel compounds, the preparation and use thereof.
ZA977206B (en) Arylalkanoylpyridazines.
HK1005962A1 (en) Alkaline cell and the preparation thereof.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA991845B (en) Catalyst and use thereof.
AU3480297A (en) Modified mcm-56, its preparation and use
ZA986421B (en) 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use.
EP0665277A3 (en) Water repellent agents, their preparation and use.
EP0671470A3 (en) Trehalose releasing enzyme, DNA encoding therefor, their preparation and uses.
ZA963620B (en) (Het)aryloxy-, -thio- and -aminocrotonates, their preparation and their use.
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
ZA987660B (en) Novel tissue-specific calpains, their preparation and use.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
AU5557698A (en) Novel calpaines, their preparation and use
HK1039339A1 (en) Outer surface proteins, their genes, and their use.
ZA976022B (en) Cycloalkano-pyridines.